Patents by Inventor Karin Margaret Ostrom

Karin Margaret Ostrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
    Patent number: 5849324
    Abstract: A method is provided for reducing the incidence of otitis media in infants and young children by enterally administering indigestible fructooligosaccharides. More specifically, the present invention relates to a method for reducing the incidence of otitis media comprising administering to humans an indigestible fructooligosaccharide selected from the group consisting of 1-kestose, nystose and 1-.sup.F -B-fructofuranosyl nystose . The indigestible fructooligosaccharides can be produced through enzymatic synthesis, chemical techniques or isolated from plant materials and are administered in the form of a nutritional product, candy, tablets, chewing gums, lozenges, milk products, yogurts and the like. In a preferred embodiment of this invention, the fructooligosaccharides have a DP of 2 to 20 and still more preferably are the fructooligosaccharides FG.sub.2, GF.sub.3, and GF.sub.4.
    Type: Grant
    Filed: June 12, 1996
    Date of Patent: December 15, 1998
    Assignee: Abbott Laboratories
    Inventors: Margaret Ione Halpin Dohnalek, Karin Margaret Ostrom, Milo Duane Hilty
  • Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
    Patent number: 5827526
    Abstract: A method is provided for reducing the duration of diarrhea and recurrent episodes of diarrhea in humans by enterally administering indigestible oligosaccharides prophylactically. More specifically, the present invention relates to a method using indigestible oligosaccharides or fructooligosaccharides (FOS) to reduce the duration and recurrence of diarrhea in a human wherein between 0.5 grams and 5 grams of at least one FOS selected from the group consisting of 1-kestose, nystose, and 1.sup.F -.beta.-fructofuranosyl nystose is administered to said human per day. The indigestible oligosaccharides can be produced through enzymatic synthesis, chemical techniques or isolated from plant materials and are administered in the form of a nutritional product, candy, tablets, chewing gum, lozenges, milk, yogurts, fermented products and the like.
    Type: Grant
    Filed: June 12, 1996
    Date of Patent: October 27, 1998
    Assignee: Abbott Laboratories
    Inventors: Margaret Ione Halpin Dohnalek, Karin Margaret Ostrom, Milo Duane Hilty